Purpose: The purpose of this report was to describe a case with paracentral acute middle maculopathy after oral intake of sumatriptan.
Methods: Case presentation.
Results: One patient showed typical findings on fundoscopic examination and optical coherence tomography consistent with paracentral acute middle maculopathy following oral intake of sumatriptan.
Conclusion: Sumatriptan may be a trigger for paracentral acute middle maculopathy.